share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

SEC announcement ·  Apr 26 13:28
Summary by Moomoo AI
James C. Smith, a reporting person for Pfizer Inc. [PFE], has been involved in a transaction with the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on their investment decisions.
James C. Smith, a reporting person for Pfizer Inc. [PFE], has been involved in a transaction with the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more